Learn if you are eligible for the HALAVEN $0 Co-Pay Program, which may be able to help you with the out-of-pocket costs of HALAVEN.
Eisai, the maker of HALAVEN, believes that cost should not be a barrier to receiving treatment. That’s why we’re committed to helping you identify what financial support may be available to you. We offer the Eisai Assistance Program (EAP). This program offers insurance information and financial support to eligible patients and caregivers for Eisai products and medicines, although Eisai cannot guarantee coverage.
*The HALAVEN $0 Co-Pay Program assists eligible patients with the out-of -pocket costs of HALAVEN (up to $18,000 per year). Restrictions apply. Visit www.eisaireimbursement.com/patient/halaven to see the full terms and conditions and eligibility requirements, to learn more about the program, and to download an enrollment form. Eligible commercially insured patients may pay as little as $0 per month, with an annual limit of $18,000. See www.eisaireimbursement.com/patient/halaven for complete eligibility requirements and terms and conditions.
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims.
HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.
HALAVEN can cause serious side effects, including
Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of HALAVEN?
HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.
The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.
Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.
For more information about HALAVEN, please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.